PubMed

Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia.

Sakaguchi H, Ikuno Y, Gomi F, Kamei M, Sawa M, Tsujikawa M, Oshima Y, Kusaka S, Tano Y.

Br J Ophthalmol. 2007 Feb;91(2):161-5. Epub 2006 Aug 16.PMID: 16914470 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results.

Ikuno Y, Sayanagi K, Soga K, Sawa M, Tsujikawa M, Gomi F, Tano Y.

Am J Ophthalmol. 2009 Jan;147(1):94-100.e1. Epub 2008 Sep 6.PMID: 18774550 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia.

Yamamoto I, Rogers AH, Reichel E, Yates PA, Duker JS.

Br J Ophthalmol. 2007 Feb;91(2):157-60. Epub 2006 Jul 26.PMID: 16870653 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.

Chan WM, Lai TY, Liu DT, Lam DS.

Ophthalmology. 2007 Dec;114(12):2190-6. Epub 2007 Jun 28.PMID: 17599414 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome.

Ruiz-Moreno JM, Montero JA, Gomez-Ulla F, Ares S.

Br J Ophthalmol. 2009 Apr;93(4):448-51. Epub 2008 Dec 17.PMID: 19091851 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization.

Mandal S, Venkatesh P, Sampangi R, Garg S.

Eur J Ophthalmol. 2007 Jul-Aug;17(4):620-6.PMID: 17671940 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results.

Gharbiya M, Allievi F, Mazzeo L, Gabrieli CB.

Am J Ophthalmol. 2009 Jan;147(1):84-93.e1. Epub 2008 Sep 6.PMID: 18774547 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results.

Arias L, Planas N, Prades S, Caminal JM, Rubio M, Pujol O, Roca G.

Br J Ophthalmol. 2008 Aug;92(8):1035-9. Review.PMID: 18653595 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab vs sub-tenon triamcinolone acetonide for choroidal neovascularization attributable to pathologic myopia.

Wakabayashi T, Ikuno Y, Gomi F, Hamasaki T, Tano Y.

Am J Ophthalmol. 2009 Oct;148(4):591-596.e1. Epub 2009 Jul 9.PMID: 19589497 [PubMed - indexed for MEDLINE]Related articles

Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia.

Hernández-Rojas ML, Quiroz-Mercado H, Dalma-Weiszhausz J, Fromow-Guerra J, Amaya-Espinosa A, Solís-Vivanco A, Reyna-Castelán E, Abraham-Marín M, Martínez-Castellanos MA, Aiello LP.

Retina. 2007 Jul-Aug;27(6):707-12.PMID: 17621179 [PubMed - indexed for MEDLINE]Related articles

Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.

Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA; Pan-American Collaborative Retina Study Group.

Retina. 2008 Nov-Dec;28(10):1387-94.PMID: 18827735 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for the treatment of choroidal neovascularization associated with pathological myopia.

Rhéaume MA, Sebag M.

Can J Ophthalmol. 2008 Oct;43(5):576-80.PMID: 18982035 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks.

Sawa M, Gomi F, Tsujikawa M, Sakaguchi H, Tano Y.

Am J Ophthalmol. 2009 Oct;148(4):584-590.e2. Epub 2009 Jul 9.PMID: 19541288 [PubMed - indexed for MEDLINE]Related articles

Treatment of choroidal neovascularization using intravitreal bevacizumab.

Pedersen R, Soliman W, Lund-Andersen H, Larsen M.

Acta Ophthalmol Scand. 2007 Aug;85(5):526-33. Epub 2007 May 18.PMID: 17511757 [PubMed - indexed for MEDLINE]Related articles

Central retinal sensitivity after intravitreal injection of bevacizumab for myopic choroidal neovascularization.

Yodoi Y, Tsujikawa A, Nakanishi H, Otani A, Tamura H, Ojima Y, Hayashi H, Yoshimura N.

Am J Ophthalmol. 2009 May;147(5):816-24, 824.e1. Epub 2009 Feb 10.PMID: 19211092 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularisation in patients with angioid streaks.

Wiegand TW, Rogers AH, McCabe F, Reichel E, Duker JS.

Br J Ophthalmol. 2009 Jan;93(1):47-51. Epub 2008 Oct 29.PMID: 18971238 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study.

Chan WM, Lai TY, Liu DT, Lam DS.

Br J Ophthalmol. 2009 Feb;93(2):150-4. Epub 2008 Sep 18.PMID: 18801766 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.

Furino C, Boscia F, Recchimurzo N, Besozzi G, Cardascia N, Sborgia L, Niro A, Sborgia C.

Acta Ophthalmol. 2009 Jun;87(4):404-7. Epub 2008 Sep 8.PMID: 18782335 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.

Chan WM, Lai TY, Liu DT, Lam DS.

Am J Ophthalmol. 2007 Jun;143(6):977-983. Epub 2007 Apr 24.PMID: 17459318 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for subfoveal idiopathic choroidal neovascularization.

Mandal S, Garg S, Venkatesh P, Mithal C, Vohra R, Mehrotra A.

Arch Ophthalmol. 2007 Nov;125(11):1487-92.PMID: 17998509 [PubMed - indexed for MEDLINE]Related articlesFree article